new year challeng limit
sourc ep upsid
new calendar year outlook remain challeng
walgreen enter calendar question plagu busi
short-term reimburs pressur pbm continu threaten retail
pharmaci profit intermedi term retail pharmaci market
rapidli evolv walgreen pilot partnership approach gener modest
benefit see head outlook core retail pharmaci
asset appear even wors like lead contract
potenti acceler market could actual serv benefit walgreen
short term compani take advantag file buy smaller pharmaci
howev struggl walgreen long-term outlook believ compani
need aggress pivot off-set continu declin retail pharmaci busi
reiter under-perform po even w/public specul potenti
explor go-priv transact see challeng link link
walgreen initi first time guidanc ahead street expect
well worst case fear howev walgreen lower guidanc first
second quarter fiscal year two past three year reimburs
pressur wors previous expect strong opex cut enough
off-set year guidanc put togeth backdrop report go-
privat convers believ similar dynam gm pressur remain place
told walgreen could see reimburs pressur acceler decemb
januari februari reimburs chang begin januari would
surpris see guidanc reduct report earli april
upcom event catalyst
report earn januari given short amount time sinc
initi guid unlik compani would look lower guidanc key focu
call earli read-through calendar reimburs trend
wba outlook growth commentari potenti go privat transact
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
walgreen follow complet rite
aid store acquisit largest global
pharmaci nearli store us
alon compani also oper intern
pharmaci busi primarili compos
boot pharmaci unit kingdom
allianc healthcar intern wholesal
distributor pharmaceut medic
product europ walgreen headquart
under-perform rate predic
pressur competit dynam
potenti increment competit
amazon small step market core
profit dollar growth slow think limit
visibl creat challeng near-term
stock perform view range-bound
estim revis expect on-going reimburs pressur squeez gm
maintain ep reduc ep
ep year reduc
gross margin assumpt us retail busi somewhat off-set lower
oper expens spend howev previou estim alreadi incorpor
signific amount net contribut target cost reduct plan
manag outlin meanwhil gross margin reduct due
continu pressur reimburs headwind necessarili see
meaning increment catalyst revers recent trend payer cut meanwhil
estim assum meaning capit deploy beyond on-going share
repurchas dividend
exhibit walgreen earn estim actual includ annual ep guidanc chang
compani file bloomberg
exhibit recent move premium still meaning discount
exhibit recent move premium still meaning discount
price object base ep multipl
five-year averag absolut basi around discount five-year
averag reflect view walgreen core retail pharmaci busi long-
term structur pressur must diversifi stabl busi line improv
upsid risk better expect gener save new partnership
healthcar area labcorp etc support long-
term growth addit volum econdisc/rit aid contribut
addit new partnership faster expect growth prime therapeut
relationship downsid risk po on-going price reimburs pressur
higher prescript attrit part relationship integr risk
risk amazon anoth disrupt forc enter suppli chain market lack
available/app attract capit deploy opportun
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
